Skip to main content
KYTX logo

KYTX

Kyverna Therapeutics, Inc.
$9.68 +0.52 (+5.68%) At close · Jul 7
Market Cap
$588.50M
Shares
60,795,212

Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.

Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-12
Kyverna Therapeutics, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.66
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-22
Kyverna AAN Conference Call
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-26
Kyverna Therapeutics, Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Kyverna Therapeutics, Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-0.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-28
Kyverna Therapeutics, Inc. Q2 FY2025 Earnings Call
Diluted EPS
$-0.97
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Kyverna Therapeutics, Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-1.03
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
Kyverna Therapeutics, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-13
Kyverna Therapeutics, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-0.80
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Kyverna Therapeutics, Inc. Q2 FY2024 Earnings Call
Diluted EPS
$-0.67
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Kyverna Therapeutics, Inc. Q1 FY2024 Earnings Call
Diluted EPS
$-1.12
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-26
Kyverna Therapeutics, Inc. Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 earnings calls
Key facts CIK 1994702 CUSIP 501976104 13F (30d) 1 filings 1 filers Visit website Investor relations